ZIP Proteins and Iron Metabolism
ZIP Proteins and Iron Metabolism
批准号:
7664317
负责人:
Mitchell D Knutson
金额:
$27.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-07-31
关键词:
AffectAgeApplications GrantsApplied GeneticsBacteriaBindingBiological ProcessCell Culture TechniquesCell membraneCellsCollaborationsDNADataDependenceDepositionDietDietary IronDioxygenDiseaseDrug or chemical Tissue DistributionElectron TransportFamilyFamily memberGenesHealthHemochromatosisHepaticHomeostasisHumanHuman bodyIndividualIntegral Membrane ProteinIntestinesIonsIronIron Metabolism DisordersIron OverloadKnock-outKnockout MiceKnowledgeLaboratoriesLeadLipidsLiverMeasuresMediatingMetabolismMetalsMolecularMorbidity - disease rateMusMutateNatureNutrientOrganismOxidation-ReductionPathway interactionsPhysiologicalPlayPrevalencePropertyProteinsPublic HealthRadiolabeledRattusReactionReactive Oxygen SpeciesRegulationRelative (related person)ResearchRoleTechniquesTestingTissuesTransfectionTransferrinTransition ElementsUp-RegulationVenous blood samplingWomanWorkZIP proteinZincbasecell typehazardin vivoiron metabolismmembermortalitynoveloverexpressionoxidationprotein transportpublic health relevanceradiotracerreproductiveresearch studytherapeutic targettraffickinguptakezinc-binding protein
中文摘要
描述(由申请方提供):铁代谢紊乱会增加发病率和死亡率,是影响人类的最常见疾病之一。在美国,近20%的育龄妇女缺铁,铁超载越来越被认为是一个公共卫生问题。尽管与这些疾病相关的患病率和不良健康影响,许多问题仍然存在关于铁转运的分子机制。这项工作的长期目标是通过研究ZIP14和其他ZIP家族成员的调节和功能来增强我们对铁稳态的理解。ZIP14最初被鉴定为锌转运蛋白,但最近的研究表明它也转运铁。其在肝脏中的丰富表达表明其在铁过载期间在肝铁沉积中起作用,并且其在静脉切开和铁缺乏时在肝脏中的上调表明其在铁摄取中起作用。这项研究的第一个目的是更全面地研究Zip14的铁依赖性调节。将使大鼠和小鼠缺铁、铁正常或铁负载,并检查各种组织的Zip14表达和细胞定位。在第二个目标中,细胞培养研究将用于确定Zip14的亚细胞定位,并研究其在转铁蛋白结合铁(细胞摄取铁的最常见途径)摄取中的作用。为了更好地定义Zip14的体内作用,第三个目标将表征Zip14敲除小鼠的铁状态。组织特异性基因敲除小鼠将用于测试Zip14在肝脏摄取非转铁蛋白结合铁和肠道摄取膳食铁中发挥作用的假设。在第四个目标中,将通过过表达蛋白质和测量放射性标记的铁的摄取来系统地评估所有哺乳动物ZIP蛋白的铁转运活性。我们还将研究体内铁状态对所有14个ZIP家族成员表达的影响。我们预计,来自Zip14实验的信息,也许还有其他ZIP蛋白,将与铁代谢紊乱有关。其他ZIP蛋白,能够运输铁或铁的状态调节的鉴定将提高我们的铁稳态和金属离子贩运一般的基本理解。铁代谢紊乱增加发病率和死亡率,是影响人类的最常见疾病之一。尽管与这些疾病相关的患病率和不良健康影响,许多问题仍然存在关于铁转运的分子机制。本提案中描述的研究将增强我们对铁转运的了解,这将最终有助于确定治疗铁代谢紊乱的治疗靶点。公共卫生相关性:铁代谢紊乱会增加发病率和死亡率,是影响人类的最常见疾病之一。尽管与这些疾病相关的患病率和不良健康影响,许多问题仍然存在关于铁转运的分子机制。本提案中描述的研究将增强我们对铁转运的了解,这将最终有助于确定治疗铁代谢紊乱的治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Nearly 20% of women of reproductive age in the US are iron deficient, and iron overload is increasingly being recognized as a public health concern. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The long-term objective of the proposed work is to enhance our understanding of iron homeostasis by investigating the regulation and function of ZIP14 and other ZIP family members. ZIP14 was first identified as a zinc transporter, but recent studies indicate that it transports iron as well. Its abundant expression in the liver suggests that it plays a role in hepatic iron deposition during iron overload, and its upregulation in liver by phlebotomy and iron deficiency suggests that it functions in iron uptake. The first aim of the proposed research will be to investigate more completely the iron-dependent regulation of Zip14. Rats and mice will be made iron deficient, iron normal, or iron loaded, and a variety of tissues will be examined for Zip14 expression and cellular localization. In the second aim, cell culture studies will be used to identify the subcellular localization of Zip14 and to investigate its role in the uptake of transferrin-bound iron, the most common pathway of iron uptake by cells. To better define the in vivo role of Zip14, the third aim will characterize the iron status of Zip14 knockout mice. Tissue-specific knockout mice will be used to test the hypotheses that Zip14 plays a role in the uptake of non-transferrin-bound iron by the liver and dietary iron by the intestine. In the fourth aim, the iron transport activity of all mammalian ZIP proteins will be systematically assessed by overexpressing the proteins and measuring the uptake of radiolabeled iron. We will also examine the effect of in vivo iron status on the expression of all 14 ZIP family members. We anticipate that information derived from the experiments with Zip14, and perhaps other ZIP proteins, will be relevant to disorders of iron metabolism. Identification of other ZIP proteins that are capable of transporting iron or are regulated by iron status will enhance our basic understanding of iron homeostasis and metal ion trafficking in general. Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The research described in this proposal will enhance our knowledge of iron transport, which will ultimately help to identify therapeutic targets for treating disorders of iron metabolism. PUBLIC HEALTH RELEVANCE: Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The research described in this proposal will enhance our knowledge of iron transport, which will ultimately help to identify therapeutic targets for treating disorders of iron metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC: The Trace Elements in Biology and Medicine Conference
-
批准号:10469205
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2022
-
负责人:Mitchell D Knutson
-
依托单位:
Zip Proteins and Iron Metabolism
-
批准号:10396019
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2009
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:7891088
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2009
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:8141398
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:8313658
-
项目类别:
-
资助金额:$26.26万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:9040152
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:8696324
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:9242009
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
ZIP Proteins and Iron Metabolism
-
批准号:7884238
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2008
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:7102607
-
项目类别:
-
资助金额:$11.3万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:6849501
-
项目类别:
-
资助金额:$5.94万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:7278826
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:6927195
-
项目类别:
-
资助金额:$11.04万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:6788076
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:6677591
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
Ferroportin and iron export from the macrophage
-
批准号:7294079
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2003
-
负责人:Mitchell D Knutson
-
依托单位:
SFT EXPRESSION IN A MOUSE MODEL OF HEMOCHROMATOSIS
-
批准号:6453553
-
项目类别:
-
资助金额:$4.2万
-
财政年份:2001
-
负责人:Mitchell D Knutson
-
依托单位:
SFT EXPRESSION IN A MOUSE MODEL OF HEMOCHROMATOSIS
-
批准号:6139940
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:Mitchell D Knutson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: